Search research articles
Contact Us
Filters
Showing results (201-210 of 212) with videos related to
Page
of 22
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 21, 2010
[Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors]
Shen Zhang, Hui Jin, Lan-Ping Xu, et al.
Journal of Food Protection
|
May 7, 2026
Direct-Fed Microbials in Diets of Market Pigs Did Not Impact Salmonella Levels, Shiga Toxin-Producing Escherichia coli, Growth Performance, and Carcass Characteristics
Jimeng Bai, Macie E Reeb, Michael D Tokach, et al.
Mediators of Inflammation
|
February 28, 2014
IL-21 modulates release of proinflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways
Su-nan Li, Wei Wang, Shou-peng Fu, et al.
International Urology and Nephrology
|
February 3, 2026
A nation-wide multi-institutional evaluation of oral versus colonic mucosal grafts for the treatment of complex long-segment urethral strictures: comparative long-term outcomes and analysis of complications from China
Ying Liu, Jing-Dong Xue, Chao Li, et al.
Blood Advances
|
March 10, 2023
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, et al.
American Journal of Cancer Research
|
March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment
Yun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2014
Quantitative and stoichiometric analysis of the microRNA content of exosomes
John R Chevillet, Qing Kang, Ingrid K Ruf, et al.
Hemasphere
|
October 9, 2024
Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia
Jin-Feng Ma, Jia-Wei Yan, Mei-Jing Liu, et al.
Nature Medicine
|
October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
Andreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
Blood Advances
|
December 8, 2022
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 212) with videos related to
Sort By:
Page
of 22
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|
August 21, 2010
[Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors]
Shen Zhang, Hui Jin, Lan-Ping Xu, et al.
Journal of Food Protection
|
May 7, 2026
Direct-Fed Microbials in Diets of Market Pigs Did Not Impact Salmonella Levels, Shiga Toxin-Producing Escherichia coli, Growth Performance, and Carcass Characteristics
Jimeng Bai, Macie E Reeb, Michael D Tokach, et al.
Mediators of Inflammation
|
February 28, 2014
IL-21 modulates release of proinflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways
Su-nan Li, Wei Wang, Shou-peng Fu, et al.
International Urology and Nephrology
|
February 3, 2026
A nation-wide multi-institutional evaluation of oral versus colonic mucosal grafts for the treatment of complex long-segment urethral strictures: comparative long-term outcomes and analysis of complications from China
Ying Liu, Jing-Dong Xue, Chao Li, et al.
Blood Advances
|
March 10, 2023
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, et al.
American Journal of Cancer Research
|
March 9, 2022
Successful application of PD-1 knockdown CLL-1 CAR-T therapy in two AML patients with post-transplant relapse and failure of anti-CD38 CAR-T cell treatment
Yun-Ju Ma, Hai-Ping Dai, Qing-Ya Cui, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 2014
Quantitative and stoichiometric analysis of the microRNA content of exosomes
John R Chevillet, Qing Kang, Ingrid K Ruf, et al.
Hemasphere
|
October 9, 2024
Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia
Jin-Feng Ma, Jia-Wei Yan, Mei-Jing Liu, et al.
Nature Medicine
|
October 23, 2023
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
Andreas Mackensen, John B A G Haanen, Christian Koenecke, et al.
Blood Advances
|
December 8, 2022
Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML
Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, et al.
Page
of 22